Allspring Global Investments’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-517
Closed -$1.47K – 2395
2024
Q1
$1.47K Buy
+517
New +$1.59K ﹤0.01% 2219
2023
Q4
– Sell
-1,851
Closed -$4.79K – 2280
2023
Q3
$4.79K Sell
1,851
-13,110
-88% -$46K ﹤0.01% 2677
2023
Q2
$58.9K Sell
14,961
-3,803
-20% -$12.1K ﹤0.01% 2248
2023
Q1
$63.4K Buy
18,764
+17,629
+1,553% +$71.9K ﹤0.01% 2206
2022
Q4
$4.06K Sell
1,135
-25
-2% -$107 ﹤0.01% 2796
2022
Q3
$4K Buy
+1,160
New +$5.96K ﹤0.01% 2790

Other funds holding SRTA

Allspring Global Investments's SRTA Position: Q2 2024 in Review

Allspring Global Investments sold out of Strata Critical Medical Inc (SRTA) in Q2 2024, closing a stake of 517 shares — an estimated $1.47K sold.

Allspring Global Investments first reported a position in SRTA in Q3 2022 and held it in 6 quarters. The position peaked at $63.4K in Q1 2023. 117 funds tracked by Wall St. Rank hold SRTA as of Q2 2024.

  • Allspring Global Investments reported no remaining Strata Critical Medical Inc position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 517 Strata Critical Medical Inc shares in Q2 2024, an estimated $1.47K.
  • Allspring Global Investments first reported a position in Strata Critical Medical Inc in Q3 2022 and held it in 6 quarters.
  • Allspring Global Investments's Strata Critical Medical Inc position peaked at $63.4K in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.